<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Vaccine Trials Initiated in Brazil and South Africa
Image Overlay - Vaccine Trials Initiated in Brazil and South Africa

Vaccine Trials Initiated in Brazil and South Africa

Vaccine Trials Initiated in Brazil and South Africa

Trials to assess the COVID-19 vaccine candidate, ChAdOx1 nCoV-19 (AZD1222), developed by the University of Oxford and licensed to AstraZeneca have kicked off in South Africa and Brazil. Trial participants include 2,000 health workers in Sao Paulo and 1,000 people in Rio de Janeiro. The trial will be South Africa’s first for coronavirus. Yourway has an advanced global depot network, with hubs in Sao Paulo and Johannesburg.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 27-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?